EU pharmaceuticals: attractively priced originals

MPA Pharma researchers search the databases for original medicinal products that are offered in other European countries at a lower price than in Germany, for example. Thanks to their extensive experience they are able to quickly identify economically promising products. 

Once an interesting product has been identified, we contact the European wholesaler to order a reference sample and inquire about its availability. Our large range of products make us an attractive provider for our business partners.  

The distribution of nationally licensed EU pharmaceuticals in the form of parallel imports requires the approval of the national competent authorities. For centrally authorised EU medicinal products, a notice of a completed notification procedure must be granted by the European Medicines Agency.

This process ensures that imported pharmaceuticals are subject to the same licensing regulations as national original products – so they are just as safe.

Our graphic designers produce packaging and information leaflets for the EU import in the corresponding national language. We notify the original manufacturers about the distribution of EU pharmaceuticals and send a sample of the final  product for review if requested. 

Our pharmaceuticals are delivered in line with good distribution practices (GDP) and legal requirements of the applicable national regulations. Our specialized logistic partners ensure strict temperature control is maintained for our pharmaceuticals right through to delivery. The vehicles constantly display the exact temperature throughout transportation. 

 At our production site, the EU pharmaceuticals are repackaged using the packaging material and leaflets designed and produced by our graphics department in the corresponding national language. 

MPA Pharma places the utmost priority on the safety and quality of EU pharmaceuticals: We monitor and document all steps of the process, from research right through to the delivery of all EU medicinal products in pristine condition, and only release the products for distribution once all quality assurance measures are completed. All products distributed by our subsidiaries EMRAmed and Paranova comply with the relevant national drug law  or the requirements of the European Medicines Agency.  

Since 9th February 2019 each prescription-based medicine repacked by MPA Pharma and distributed by EMRAmed receives a 2D code with plain text, including a uniquely serialisation number and a tamper-evident closure, guaranteeing the integrity of the packaging by means of seals.

As soon as the products are repackaged and quality-checked, our distribution department adds the imported medicinal products  to the product range and publishes it in the database where pharmacies and pharmaceutical wholesalers can look up and order all pharmaceuticals licensed for the respective market.

The orders that are placed every day by pharmacies and pharmaceutical wholesalers are delivered on the same day or within 24 hours. Our customers can contact our personal advisors for assistance during any stage of the ordering process. 

The distribution of lower cost imported EU pharmaceuticals contributes towards lowering the cost of the health care system and helps pharmacies in Germany to fill the mandatory import quotas. EU medicinal products purchased from EMRAmed or Paranova allow patients to help stabilise the costs for the national health care.